Evidence map›Paper›PMID 31185608›Full record

ArticleInternational journal of molecular sciences2019

RTA 408 Inhibits Interleukin-1β-Induced MMP-9 Expression via Suppressing Protein Kinase-Dependent NF-κB and AP-1 Activation in Rat Brain Astrocytes.

Chien-Chung Yang, Chih-Chung Lin, Mei-Jie Jou, Li-Der Hsiao, Chuen-Mao Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408.International journal of chronic obstructive pulmonary disease · 2024
    Article
  8. International journal of medical sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Crosstalk between neuroinflammation and oxidative stress in epilepsy.Frontiers in cell and developmental biology · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Chien-Chung YangDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Tao-Yuan, Kwei-San, Tao-Yuan 333, Taiwan. r55161@cgmh.org.tw.
Chih-Chung LinDepartment of Anesthetics, Chang Gung Memorial Hospital at Linkuo, and College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan 333, Taiwan. chihchung@adm.cgmh.org.tw.
Mei-Jie JouDepartment of Physiology and Pharmacology and Health Ageing Research Center, College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan 333, Taiwan. mjjou@mail.cgu.edu.tw.
Li-Der HsiaoDepartment of Anesthetics, Chang Gung Memorial Hospital at Linkuo, and College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan 333, Taiwan. lidesiao@livemail.tw.
Chuen-Mao YangDepartment of Anesthetics, Chang Gung Memorial Hospital at Linkuo, and College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan 333, Taiwan. chuenmao@mail.cgu.edu.tw.
Chang Gung Memorial Hospital · TWChang Gung University · TWChang Gung University of Science and Technology · TW

Funding

Chang Gung Medical Foundation CMRPD1F0023Chang Gung Medical Foundation CMRPD1F0553Chang Gung Medical Foundation CMRPD1I0051Chang Gung Medical Foundation CMRPG3F1533Chang Gung Medical Foundation CMRPG3H0062Chang Gung Medical Foundation CMRPG3H0063Chang Gung Medical Foundation CMRPG5F0203Chang Gung Medical Foundation CMRPG5I0041Ministry of Education EMRPD1I0381Ministry of Science and Technology, Taiwan MOST105-2320-B-182-005-MY3Ministry of Science and Technology, Taiwan MOST107-2320-B-182-020-MY2Ministry of Science and Technology, Taiwan MOST107-2320-B-182A-011
6 · The paper itself

Abstract

Neuroinflammation is characterized by the elevated expression of various inflammatory proteins, including matrix metalloproteinases (MMPs), induced by various pro-inflammatory mediators, which play a critical role in neurodegenerative disorders. Interleukin-1β (IL-1β) has been shown to induce the upregulation of MMP-9 through nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX)-reactive oxygen species (ROS)-dependent signaling pathways. N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2-2-difluoropropanamide (RTA 408), a novel synthetic triterpenoid, has been shown to possess anti-oxidant and anti-inflammatory properties in various types of cells. Here, we evaluated the effects of RTA 408 on IL-1β-induced inflammatory responses by suppressing MMP-9 expression in a rat brain astrocyte (RBA-1) line. IL-1β-induced MMP-9 protein and mRNA expression, and promoter activity were attenuated by RTA 408. The increased level of ROS generation in RBA-1 cells exposed to IL-1β was attenuated by RTA 408, as determined by using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) and CellROX. In addition, the inhibitory effects of RTA 408 on MMP-9 expression resulted from the suppression of the IL-1β-stimulated activation of Pyk2 (proline-rich tyrosine kinase), platelet-derived growth factor receptor β (PDGFRβ), Akt, ROS, and mitogen-activated protein kinases (MAPKs). Pretreatment with RTA 408 attenuated the IL-1β-induced c-Jun phosphorylation, mRNA expression, and promoter activity. IL-1β-stimulated nuclear factor-κB (NF-κB) p65 phosphorylation, translocation, and promoter activity were also attenuated by RTA 408. Furthermore, IL-1β-induced glial fibrillary acidic protein (GFAP) protein and mRNA expression, and cell migration were attenuated by pretreatment with RTA 408. These results provide new insights into the mechanisms by which RTA 408 attenuates IL-1β-mediated inflammatory responses and exerts beneficial effects for the management of brain diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsAstrocytesBrainCell LineInterleukin-1betaMAP Kinase Signaling SystemMatrix Metalloproteinase 9NF-kappa BRatsTranscription Factor AP-1TriterpenesAnti-Inflammatory AgentsInterleukin-1betaMatrix Metalloproteinase 9Mmp9 protein, ratNF-kappa BomaveloxoloneTranscription Factor AP-1TriterpenesastrocytesChinese herbal medicineIL-1βmatrix metalloproteinaseneuroinflammation

Identifiers

PMID31185608
PMCPMC6600142
OpenAlexW2948206610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.